Abilify, the antipsychotic developed by the Japanese Otsuka Group, is listed as the number four top-selling pharmaceutical, according to the influence.
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.